Establishment of a canine urothelial carcinoma-derived organoid biobank: A platform for comparative and translational research

Christopher Zdyrski , Aleksandra Pawlak , Hannah F. Nicholson , Megan P. Corbett , Michael Catucci , John Cheville , Haejin Cho , Bryan J. Melvin , Jiayi Peng , Corey Saba , Hayden Hamsher , Steven G. Friedenberg , Andrew P. Woodward , Eugene Douglass , Jonathan P. Mochel , Karin Allenspach

Clinical and Translational Medicine ›› 2026, Vol. 16 ›› Issue (4) : e70645

PDF (3833KB)
Clinical and Translational Medicine ›› 2026, Vol. 16 ›› Issue (4) :e70645 DOI: 10.1002/ctm2.70645
LETTER TO THE JOURNAL
Establishment of a canine urothelial carcinoma-derived organoid biobank: A platform for comparative and translational research
Author information +
History +
PDF (3833KB)

Cite this article

Download citation ▾
Christopher Zdyrski, Aleksandra Pawlak, Hannah F. Nicholson, Megan P. Corbett, Michael Catucci, John Cheville, Haejin Cho, Bryan J. Melvin, Jiayi Peng, Corey Saba, Hayden Hamsher, Steven G. Friedenberg, Andrew P. Woodward, Eugene Douglass, Jonathan P. Mochel, Karin Allenspach. Establishment of a canine urothelial carcinoma-derived organoid biobank: A platform for comparative and translational research. Clinical and Translational Medicine, 2026, 16 (4) : e70645 DOI:10.1002/ctm2.70645

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Knapp DW, Glickman NW, DeNicola DB, et al. Naturally-occurring canine transitional cell carcinoma of the urinary bladder: a relevant model of human invasive bladder cancer. Urologic Oncology: Seminars and Original Investigations. Elsevier; 2000: 47-59.

[2]

Elbadawy M, Zdyrski C, Wickham H, et al. Experimental methods for establishing and maintaining canine bladder cancer organoids. Cancer Detection and Diagnosis. CRC Press; 2025: 505-513.

[3]

Chen D, Xu L, Xuan M, et al. Unveiling the functional roles of patient-derived tumour organoids in assessing the tumour microenvironment and immunotherapy. Clin Transl Med. 2024; 14(9):e1802.

[4]

Kamoun A, de Reyniès A, Allory Y, et al. A consensus molecular classification of muscle-invasive bladder cancer [formula presented]. Eur Urol. 2020; 77: 420-433.

[5]

Robertson AG, Kim J, Al-Ahmadie H, et al. Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell. 2017; 171: 540-556.e25.

[6]

Guo Z, Li Z, Wang J, et al. Modeling bladder cancer in the laboratory: insights from patient-derived organoids. Biochim Biophys Acta Rev Cancer. 2024; 1879(6):189199.

[7]

Medle B, Sjödahl G, Eriksson P, et al. Patient-derived bladder cancer organoid models in tumor biology and drug testing: a systematic review. Cancers (Basel). 2022; 14(9): 2062.

[8]

Neuhaus J, Rabien A, Reinhold A, et al. 3D tumor models in urology. Int J Mol Sci. 2023; 24(7): 6232.

[9]

Radić M, Egger M, Kruithof-de Julio M, Seiler R. Patient-derived organoids in bladder cancer: opportunities and challenges. Eur Urol Focus. 2025;11:62-70.

[10]

Liberzon A, Birger C, Thorvaldsdóttir H, et al. The molecular signatures database hallmark gene set collection. Cell Syst. 2015; 1: 417-425.

RIGHTS & PERMISSIONS

2026 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.

PDF (3833KB)

3

Accesses

0

Citation

Detail

Sections
Recommended

/